These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17289876)

  • 21. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
    N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
    Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
    Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
    Børresen-Dale AL; Lothe RA; Meling GI; Hainaut P; Rognum TO; Skovlund E
    Clin Cancer Res; 1998 Jan; 4(1):203-10. PubMed ID: 9516972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.
    Dunn J; Garde J; Dolan K; Gosney JR; Sutton R; Meltzer SJ; Field JK
    Oncogene; 1999 Jan; 18(4):987-93. PubMed ID: 10023674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
    Hirao S; Hirao T; Marsit CJ; Hirao Y; Schned A; Devi-Ashok T; Nelson HH; Andrew A; Karagas MR; Kelsey KT
    Cancer; 2005 Nov; 104(9):1918-23. PubMed ID: 16149093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
    Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
    Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
    Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
    Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA
    Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.